Dafna Capital Management LLC Aptinyx Inc. Transaction History

Dafna Capital Management LLC

  • $390 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019
SELL
$3.99 - $19.33 $57,855 - $280,285
-14,500 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$20.21 - $31.85 $212,205 - $334,425
-10,500 Reduced 42.0%
14,500 $420,000
Q2 2018

Aug 13, 2018
BUY
$19.83 - $24.17 $495,749 - $604,250
25,000 New
25,000 $604,000

About Aptinyx Inc.

APTX Quotes by TradingView
  • Ticker APTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,715,696
  • Description
  • Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...
More about APTX
Track This Portfolio

Track Dafna Capital Management LLC Portfolio

Follow Dafna Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email